Related Experiment Videos
Discussant--pathophysiologies of Rett syndrome
1Segawa Neurological Clinic for Children, 2-8 Surugadai, Kanda Chiyodaku, 101-0062, Tokyo, Japan. segawa@t3.rim.or.jp
Brain & Development
|December 12, 2001
Summary
Rett syndrome involves early hypoactivity in noradrenaline and serotonin neurons, impacting brain development. This leads to motor and language disabilities, linked to MECP2 gene mutations.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- Rett syndrome is a neurodevelopmental disorder.
- Early infancy shows hypoactivity in noradrenaline (NA) and serotonin (5HT) neurons, with preserved dopamine (DA) and cholinergic neuron function.
- Sleep-wake cycle development is arrested at the 4-month level.
Purpose of the Study:
- Investigate the neurobiological underpinnings of Rett syndrome.
- Identify the specific neuronal pathways and genetic factors involved.
- Correlate clinical manifestations with molecular pathology.
Main Methods:
- Polysomnography to assess sleep parameters.
- Neurohistochemical and neuroimaging (PET) studies.
- Analysis of MECP2 gene mutations.
Main Results:
- Hypofunction of nigrostriatal (NS)-DA neurons in early childhood, with receptor supersensitivity later.
- Cholinergic neuron involvement in cortical pathology.
- Correlation between motor and language disability grades and MECP2 mutation loci.
- Absence of NA and 5HT neuron pathology in the brainstem.
Conclusions:
- Primary lesion in brainstem NA and 5HT neurons affects cortical synaptogenesis and pedunculopontine nuclei (PPN) function.
- PPN dysfunction leads to midbrain DA and cholinergic neuron dysfunction.
- MECP2 mutations may trigger premature gene transcription, affecting aminergic neuron axon pruning during development.